Clearside Biomedical to Present at the 2019 Wedbush PacGrow Healthcare Conference
06 Agosto 2019 - 3:35PM
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical
company dedicated to developing treatments that restore and
preserve vision for people with serious eye diseases, announced
today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer, will
present a company overview at the 2019 Wedbush PacGrow Healthcare
Conference in New York, NY on Tuesday, August 13, 2019 at 12:45
p.m. ET.
A link to the live and archived webcast may be
accessed on the Clearside website under the Investors section:
Events and Presentations. An archive of the webcast will be
available for three months.
About Clearside Biomedical
Clearside Biomedical, Inc. is a
biopharmaceutical company dedicated to developing treatments that
restore and preserve vision for people with serious eye diseases.
Clearside’s proprietary SCS Microinjector™ targeting the
suprachoroidal space (SCS) offers unprecedented access to the back
of the eye where sight-threatening disease often occurs. The
Company’s SCS injection platform is an inherently flexible,
in-office, non-surgical procedure, intended to work with
established medications, new formulations of medicines, as well as
future therapeutic innovations such as gene therapy. Clearside is
headquartered in Alpharetta, GA. For more information, please visit
www.clearsidebio.com.
Investor and Media Contacts: Jenny Kobin Remy
Bernarda ir@clearsidebio.com(678) 430-8206
Source: Clearside Biomedical, Inc.
Clearside Biomedical (NASDAQ:CLSD)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Clearside Biomedical (NASDAQ:CLSD)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024